Literature DB >> 23884367

Crystal structure of Junin virus nucleoprotein.

Yinjie Zhang1,2,3, Le Li1,2, Xiang Liu1, Shishang Dong1,2, Wenming Wang1,2, Tong Huo1,2,3, Yu Guo3, Zihe Rao1,2,3, Cheng Yang1,2,3.   

Abstract

Junin virus (JUNV) has been identified as the aetiological agent of Argentine haemorrhagic fever (AHF), which is a serious public health problem with approximately 5 million people at risk. It is treated as a potential bioterrorism agent because of its rapid transmission by aerosols. JUNV is a negative-sense ssRNA virus that belongs to the genus Arenavirus within the family Arenaviridae, and its genomic RNA contains two segments encoding four proteins. Among these, the nucleoprotein (NP) has essential roles in viral RNA synthesis and immune suppression, but the molecular mechanisms of its actions are only partially understood. Here, we determined a 2.2 Å crystal structure of the C-terminal domain of JUNV NP. This structure showed high similarity to the Lassa fever virus (LASV) NP C-terminal domain. However, both the structure and function of JUNV NP showed differences compared with LASV NP. This study extends our structural insight into the negative-sense ssRNA virus NPs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884367     DOI: 10.1099/vir.0.055053-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.

Authors:  Baocheng Liu; Shishang Dong; Guobang Li; Wenming Wang; Xiang Liu; Yantong Wang; Cheng Yang; Zihe Rao; Yu Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.

Authors:  Elizabeth J Mateer; Junki Maruyama; Galen E Card; Slobodan Paessler; Cheng Huang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses.

Authors:  Hector Moreno; Rebecca Möller; Chiara Fedeli; Gisa Gerold; Stefan Kunz
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

Review 4.  The Virus-Host Interplay in Junín Mammarenavirus Infection.

Authors:  Giovanna Lucrecia Gallo; Nora López; María Eugenia Loureiro
Journal:  Viruses       Date:  2022-05-24       Impact factor: 5.818

5.  Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression.

Authors:  Brandyn R West; Kathryn M Hastie; Erica Ollmann Saphire
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-05-30

6.  Differential contributions of tacaribe arenavirus nucleoprotein N-terminal and C-terminal residues to nucleocapsid functional activity.

Authors:  Alejandra D'Antuono; Maria Eugenia Loureiro; Sabrina Foscaldi; Cristina Marino-Buslje; Nora Lopez
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

7.  RNA nanotechnology to build a dodecahedral genome of single-stranded RNA virus.

Authors:  Hui Li; Kaiming Zhang; Daniel W Binzel; Lyudmila S Shlyakhtenko; Yuri L Lyubchenko; Wah Chiu; Peixuan Guo
Journal:  RNA Biol       Date:  2021-04-29       Impact factor: 4.652

8.  Watching every step of the way: junín virus attenuation markers in the vaccine lineage.

Authors:  Betina Inés Stephan; Mario Enrique Lozano; Sandra Elizabeth Goñi
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

Review 9.  IFITMs restrict the replication of multiple pathogenic viruses.

Authors:  Jill M Perreira; Christopher R Chin; Eric M Feeley; Abraham L Brass
Journal:  J Mol Biol       Date:  2013-09-25       Impact factor: 5.469

10.  Visualization of Double-Stranded RNA Colocalizing With Pattern Recognition Receptors in Arenavirus Infected Cells.

Authors:  Elizabeth J Mateer; Slobodan Paessler; Cheng Huang
Journal:  Front Cell Infect Microbiol       Date:  2018-07-24       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.